Pharmaust Ltd v Advance Healthcare Group Ltd

In the Federal Court of Australia, Pharmaust Ltd filed an action against Advance Healthcare Group Ltd concerning disputes related to a pharmaceutical product distribution agreement. The plaintiff sought various remedies, including declarations and an account of profits, related to alleged breaches of the agreement by the defendant. The case involved complex contractual disputes and issues of equitable relief. The court was tasked with deciding whether the plaintiff's application to discontinue the action should be granted without any order as to costs, considering the arguments presented by both parties regarding the circumstances under which the proceedings had become futile.

The primary legal issues before the court were whether the proceedings had been rendered futile by a supervening event and whether the plaintiff had acted unreasonably in pursuing the action. The court had to consider the principle that a party seeking to discontinue proceedings without paying costs must demonstrate that the proceedings were futile. This involved evaluating the likelihood of success at the time the action was commenced and whether any supervening events had changed the circumstances to the extent that the proceedings were rendered futile. The court also needed to assess whether the plaintiff's decision to pursue the action was reasonable given the available information at the time.

The court found that the proceedings had indeed become futile due to a significant change in the market conditions and the commercial relationship between the parties, which occurred after the action was commenced. This supervening event made the relief sought by the plaintiff less viable and effectively negated the basis for the legal action. Additionally, the court determined that the plaintiff had not acted unreasonably in initially pursuing the action, as the circumstances leading to the change in market conditions were not foreseeable at the time. Consequently, the court granted both parties leave to discontinue the action without any order as to costs, including reserved costs.

The final orders of the court allowed Pharmaust Ltd and Advance Healthcare Group Ltd to discontinue the action without incurring costs, reflecting the court's determination that the proceedings had become futile due to the supervening event and that neither party had acted unreasonably in pursuing the action up to that point.